Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
746 studies found for:    Open Studies | "Anticoagulants"
Show Display Options
Rank Status Study
1 Not yet recruiting Bleeding Frequency Under Anticoagulant Treatment in Pulmonary Hypertension
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: Oral anticoagulant treatment
2 Not yet recruiting Safety of Oral Anticoagulants Registry
Condition: Blood Coagulation
Intervention: Other: mgt of bleeding concerns/complications of oral anticoagulants
3 Recruiting Direct Oral Anticoagulants Pharmacodynamics in Octogenarian Patients With Atrial Fibrillation
Condition: Atrial Fibrillation and Flutter
Intervention: Other: New oral anticoagulant pharmacodynamic analysis (blood level assesment)
4 Not yet recruiting COMBO-Stent in Patients on Chronic Anticoagulant Therapy (COSTA) COSTA-Bleed and COSTA-Outcome Trials
Conditions: Stable Angina;   Unstable Angina;   STEMI;   NSTEMI;   Coronary Disease
Interventions: Device: COMBO-Stent;   Drug: Clopidogrel, Vitamin K Antagonist, Rivaroxaban, Dabigatran;   Device: Any drug eluting stent oder bare metal sent;   Drug: ASA, Clopidogrel, Vitamin K Antagonist, Rivaroxaban, Dabigatran
5 Recruiting Clinical Trial for Optimal Novel Oral Anticoagulant (NOAC) Schedule Immediate Before Catheter Ablation for Atrial Fibrillation
Condition: Atrial Fibrillation
Interventions: Drug: novel oral anticoagulant for 30 days;   Drug: novel oral anticoagulant for 24 hour
6 Not yet recruiting SILENT - Subclinical AtrIal FibrilLation and StrokE PreveNtion Trial
Condition: Atrial Fibrillation
Intervention: Drug: anticoagulant by physician criteria
7 Not yet recruiting Venous Thromboembolism in Renally Impaired Patients and Direct Oral Anticoagulants
Condition: Renal Insufficiency
Interventions: Drug: Apixaban;   Drug: Rivaroxaban;   Drug: Heparin;   Drug: VKA
8 Recruiting A Study of the Safety and Effectiveness of Apixaban in Preventing Blood Clots in Children With Leukemia Who Have a Central Venous Catheter and Are Treated With PEG L-Asparaginase
Conditions: Lymphoma;   Acute Lymphoblastic Leukemia
Interventions: Drug: Apixaban;   Other: No systemic anticoagulant prophylaxis
9 Recruiting Exposure of Salvaged Blood to Inflammation and Oxidative Stress: the Effect of Different Anticoagulant Regimes (HECICS)
Condition: Intra Operative Bleeding, Blood Salvage
Interventions: Drug: ACD-A;   Drug: Heparin
10 Recruiting Influence of ABCB1 Polymorphisms on Plasma Concentrations of New Oral Anticoagulants in Case of Serious Adverse Events
Conditions: Anticoagulants;   Thromboembolism;   Hemorrhage
Interventions: Other: Measurement of Plasma Concentrations of NOACs;   Genetic: Identification of ABCB1 polymorphisms coding for P-gp
11 Recruiting START-Register: Survey on Anticoagulated Patients Register
Conditions: Atrial Fibrillation;   Venous Thromboembolism;   Heart Valve Diseases or Prosthesis;   Other Heart or Peripheral Vascular Diseases Leading to Chronic Anticoagulation
Intervention: Drug: Anticoagulants
12 Recruiting Novel Oral Anticoagulants in Stroke Patients
Conditions: Ischemic Stroke,;   Intracranial Hemorrhage,
13 Recruiting Evaluation of the Use of Apixaban in Prevnetion of Thromboembolic Disease in Patients With Myeloma Trated With iMiDs
Conditions: Myeloma;   Venous Thromboembolism
Intervention: Drug: Apixaban
14 Unknown  Anticoagulant Treatments and Percutaneous Coronary Angioplasty
Condition: Coronary Artery Disease
Interventions: Drug: clopidogrel + aspirin;   Drug: heparin + clopidogrel + aspirin;   Drug: enoxaparin + clopidogrel + aspirin;   Drug: bivalirudin + clopidogrel + aspirin
15 Recruiting Registry of Acute Stroke Under Novel Oral Anticoagulants - Prime
Conditions: Ischemic Stroke;   Intracerebral Hemorrhage;   Oral Anticoagulation;   Cardiovascular Diseases;   Vascular Diseases
Intervention: Other: not applicable (observational study)
16 Recruiting New Oral Direct Anticoagulants in Patients 80 Years Old and Over : a Population Pharmacokinetics Study
Condition: Atrial Fibrillation
Intervention: Other: Plasma drug concentrations
17 Recruiting Evaluation of the Duration of Therapy for Thrombosis in Children
Condition: Venous Thrombosis
Interventions: Other: Shortened duration (6 weeks) of anticoagulant therapy;   Other: Conventional duration (3 months) of anticoagulant therapy;   Other: No Intervention
18 Unknown  Benefits of a Comprehensive Patient Education on Oral Anticoagulant Compared to Conventional Hospital Education
Condition: Cardiac Surgery
Interventions: Behavioral: VKA (antivitamin K) education;   Behavioral: conventional hospital education
19 Not yet recruiting Benefit/Risk in Real Life of New Oral Anticoagulants and Vitamin K Antagonists in Patients Aged 80 Years and Over
Condition: Atrial Fibrillation
Interventions: Drug: Direct oral antocoagulant: dabigatran, rivaroxaban, apixaban;   Drug: Vitamin K antagonist: warfarin, fluindione, acenocoumarol
20 Not yet recruiting The Strategy to Prevent Hemorrhage Associated With Anticoagulation in Renal Disease Management (STOP HARM) Trial
Conditions: Chronic Kidney Disease;   Acute Bleeding;   Cerebrovascular Stroke
Interventions: Device: Watchman;   Drug: Continued therapy with the prescribed oral anticoagulant

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years